Clinical Trials Logo

Clinical Trial Summary

The primary aim of our prospective, randomized, double-blind interventional clinical trial is to determine the effectiveness of high dose atorvastatin therapy to reduce post operative cognitive dysfunction (POCD) in patients undergoing cardiac valve surgery. We hypothesize that therapy with high dose atorvastatin will significantly reduce the incidence and/or severity of POCD.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT01186289
Study type Interventional
Source Duke University
Contact
Status Withdrawn
Phase N/A
Start date October 2010
Completion date October 2012

See also
  Status Clinical Trial Phase
Completed NCT04005456 - Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket Design N/A
Enrolling by invitation NCT06227962 - Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors
Completed NCT04038788 - Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia N/A
Recruiting NCT05077748 - An 18-year Follow-up Study on OSA in a Population-based Cohort
Recruiting NCT03606421 - CBF and NCF Changes With Brain Radiation
Recruiting NCT03709199 - Long Term Follow up of Children Enrolled in the REDvent Study
Recruiting NCT04458207 - Cognitive Changes and Neural Correlates After Rehabilitation of Masticatory Function in Elderly -an Intervention Study N/A
Recruiting NCT05363332 - Impact and Sequelae of High Ventilatory Drive in Critically Ill COVID-19 Patients
Recruiting NCT03886675 - Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection N/A
Enrolling by invitation NCT04373525 - Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users
Enrolling by invitation NCT04881266 - Long-Term Functional, Quality-of-Life, Neuropsychological and Cognitive Outcomes in COVID-19 Critical Illness Survivors
Completed NCT03795454 - Can Singing Kangaroo Improve Outcome of Preterm Infants N/A
Recruiting NCT05019300 - Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors.
Not yet recruiting NCT05245903 - Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
Terminated NCT03163277 - Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X) Phase 4
Not yet recruiting NCT06224088 - Neuro-cognitive Function 1 Year Post ICU Discharge Among VV ECMO Survivors
Completed NCT03460821 - Validation of a German Translation and Cultural Adaptation of the Addenbrooke's Cognitive Examination III
Not yet recruiting NCT06413173 - Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric) N/A
Terminated NCT03863639 - Changes in fMRI and Neurocognitive Function in Women With Pre-eclampsia
Enrolling by invitation NCT03567304 - Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine Phase 4